Vimarsana
Biggest News Aggregation in the World

Life Sciences Instrument News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Instrument. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Instrument Today - Breaking & Trending Today

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript - Vimarsana News

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript

Published: May 1, 2024

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript April 29, 2024 Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and welcome to the Q1 2024 […]

Source: yahoo.com
Related Topics:
Max KrakowiakOur Life Sciences InstrumentTour Life SciencesSpecialty Pharma ServicesLife SciencesReagents Technology LicensingOur Signal SoftwareRevvity Omics LabInvestor RelationsLife Sciences InstrumentSignal SoftwareNewborn ScreeningApplied GenomicsSteve WilloughbyPrahlad SinghNewborn Screening
Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript - Vimarsana News

Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript

Published: May 1, 2024

Revvity, Inc. beats earnings expectations. Reported EPS is $0.98, expectations were $0.94. Revvity, Inc.

Source: insidermonkey.com
Related Topics:
San DiegoUnited StatesJoshua WaldmanMichael RyskinVijay KumarMax KrakowiakJosh WaldmanOxford ImmunotecSteve WilloughbyAndrew CooperRaymond JamesDoug SchenkelPatrick DonnellyJack MeehanPrahlad SinghMatt SykesMatthew SykesNephron ResearchCleveland ResearchLife Sciences ReagentsLife SciencesOur Life Sciences InstrumentRevvity Omics LabLife Sciences Or Applied GenomicsRevvity Signals Software